ARTICLE | Company News
SRA, ZymoGenetics autoimmune deal
September 4, 2001 7:00 AM UTC
Serono (SRA; SWX:SEO) entered an exclusive co-development and commercialization deal with ZymoGenetics (Seattle, Wash.) to develop one or more products based on two molecules -- TACI and BCMA -- that ...